Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02267538Phase 4Completed
Phase 4, randomised, double-blind trial in postoperative delirium (POD) comparing Dexmedetomidine with Placebo (2 arms). Primary endpoint: Incidence of Postoperative Delirium at 5 days. Started Nov 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02267538.